The present invention refers to a new process for the synthesis of the pharmaceutical active ingredient Lapatinib and the salts thereof.In particular, the present synthesis is performed using intermediates in which the hydroxyl function is protected by the tetrahydropyranyl group hence entailing greater solubility of the intermediates in the common organic solvents.